ArticleOncology letters2015

Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma.

Qi-Fu Bo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.